发明名称 LEVODOPA / CARBIDOPA / ENTACAPONE PHARMACEUTICAL PREPARATION
摘要 The invention relates to an oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or a pharmaceutically acceptable salt or hydrate thereof, and comprising at lea st one pharmaceutically acceptable excipient. The composition of the invention can be used e.g. for the treatment of Parkinson's disease.
申请公布号 CA2378469(A1) 申请公布日期 2001.01.11
申请号 CA20002378469 申请日期 2000.06.29
申请人 ORION CORPORATION 发明人 NISKANEN, MERVI;PARTANEN, MARJA;RITALA, MARJA;LINTULAAKSO, JARMO;VIRKKI, MATTI;LAAKSONEN, MARJA;VAHERVUO, KARI;KERVINEN, LASSE;KALLIOINEN, SARI
分类号 A61K9/00;A61K9/16;A61K9/20;A61K9/26;A61K31/192;A61K31/195;A61K31/198;A61K31/275;A61K31/277;A61K36/47;A61K47/10;A61K47/26;A61K47/36;A61K47/44;A61P25/16;(IPC1-7):A61K31/198 主分类号 A61K9/00
代理机构 代理人
主权项
地址